1. Home
  2. GH
  3. GH News

Latest Guardant Health Inc. (GH) News on January 22, 2025

Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients
GH

Business Wire

a day ago

Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients

Guardant Health, Inc. (GH) Partners with ConcertAI to Launch Advanced Real-World Data Solution for Enhanced Cancer Treatment and Clinical Trials
GH

Insider Monkey

2 days ago

Guardant Health, Inc. (GH) Partners with ConcertAI to Launch Advanced Real-World Data Solution for Enhanced Cancer Treatment and Clinical Trials

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'
GH

Investor's Business Daily

6 days ago

Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?'

GH

MT Newswires

6 days ago

Guardant Health, ConcertAI Working Together on Cancer Treatments

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development
GH

Business Wire

6 days ago

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue
GH

Medical Device Network

8 days ago

JP Morgan 2025: Guardant reports $737m in preliminary full-year revenue

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results
GH

Business Wire

9 days ago

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

GH

MT Newswires

12 days ago

Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
GH

Business Wire

15 days ago

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
GH

Zacks

15 days ago

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
GH

Business Wire

20 days ago

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
GH

Business Wire

a month ago

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

GH

MT Newswires

a month ago

Guardant Health, COTA Collaborate to Provide Combined Data for Cancer Research

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics
GH

Business Wire

a month ago

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics

GH

MT Newswires

a month ago

Guardant Health, Boehringer Collaborate on Companion Test for Potential Lung Cancer Drug

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer
GH

Business Wire

a month ago

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium
GH

Business Wire

a month ago

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week
GH

Simply Wall St.

2 months ago

Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week

Guardant awarded nearly $293M in false ad trial against Natera
GH

MedTech Dive

2 months ago

Guardant awarded nearly $293M in false ad trial against Natera

GH

MT Newswires

2 months ago

Guardant Health Wins False Advertising Suit Against Natera

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™
GH

PR Newswire

2 months ago

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds
GH

Insider Monkey

2 months ago

Guardant Health, Inc. (GH): Among the Most Promising Cancer Stocks According to Hedge Funds

Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market
GH

Insider Monkey

2 months ago

Guardant Health (GH) Set To Dominate The Growing Liquid Biopsy Market

Guardant Health Stock Sees RS Rating Jump To 83
GH

Investor's Business Daily

2 months ago

Guardant Health Stock Sees RS Rating Jump To 83

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GH

Business Wire

2 months ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
GH

Motley Fool

2 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Guardant Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GH

Simply Wall St.

2 months ago

Guardant Health Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Why Guardant Health Stock Blasted 13% Higher on Thursday
GH

Motley Fool

2 months ago

Why Guardant Health Stock Blasted 13% Higher on Thursday

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop
GH

Investor's Business Daily

2 months ago

Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop

GH

Morningstar Research

2 months ago

Analyst Report: Guardant Health, Inc.

Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
GH

GuruFocus.com

2 months ago

Guardant Health Inc (GH) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
GH

Zacks

3 months ago

Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

GH

Morningstar Research

3 months ago

Analyst Report: Guardant Health, Inc.

Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
GH

Zacks

3 months ago

Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates

GH

Associated Press Finance

3 months ago

Guardant Health: Q3 Earnings Snapshot

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
GH

Business Wire

3 months ago

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics
GH

Zacks

3 months ago

Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics

Guardant Health to Participate in Upcoming Investor Conferences
GH

Business Wire

3 months ago

Guardant Health to Participate in Upcoming Investor Conferences

Why Guardant Health Stock Was the Picture of Health Today
GH

Motley Fool

3 months ago

Why Guardant Health Stock Was the Picture of Health Today

Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know
GH

Zacks

3 months ago

Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know

Guardant Health Named to TIME’s List of the Best Inventions of 2024
GH

Business Wire

3 months ago

Guardant Health Named to TIME’s List of the Best Inventions of 2024

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
GH

Business Wire

3 months ago

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024

Roberto A. Mignone Joins Guardant Health Board of Directors
GH

Business Wire

3 months ago

Roberto A. Mignone Joins Guardant Health Board of Directors

Is There An Opportunity With Guardant Health, Inc.'s (NASDAQ:GH) 43% Undervaluation?
GH

Simply Wall St.

3 months ago

Is There An Opportunity With Guardant Health, Inc.'s (NASDAQ:GH) 43% Undervaluation?

Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
GH

Business Wire

3 months ago

Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024

Deep Track Capital, LP Increases Stake in Guardant Health Inc
GH

GuruFocus.com

3 months ago

Deep Track Capital, LP Increases Stake in Guardant Health Inc

GH

Morningstar Research

4 months ago

Analyst Report: Guardant Health, Inc.

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
GH

Business Wire

4 months ago

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long

The Battle Brewing Over Blood Tests for Cancer
GH

The Wall Street Journal

4 months ago

The Battle Brewing Over Blood Tests for Cancer

GH

MT Newswires

4 months ago

Top Premarket Decliners

Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
GH

Business Wire

4 months ago

Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?
GH

Zacks

4 months ago

Liquidia Technologies (LQDA) Soars 14.1%: Is Further Upside Left in the Stock?

GH

MT Newswires

4 months ago

Guardant Health, Policlinico Gemelli Collaborate on Liquid Biopsy Testing Service

Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
GH

Business Wire

4 months ago

Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy

Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
GH

Business Wire

5 months ago

Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

GH

MT Newswires

5 months ago

Top Midday Decliners

GH

MT Newswires

5 months ago

Sector Update: Health Care Stocks Ease in Afternoon Trading

GH

Investing.com

5 months ago

Midday movers: PDD Holdings, NVIDIA fall; Xpeng gains

GH

MT Newswires

5 months ago

Update: Guardant Health Shares Fall After $400 Million Share Sale Plan

Why Guardant Health Stock Just Crashed 10%
GH

Motley Fool

5 months ago

Why Guardant Health Stock Just Crashed 10%

GH

MT Newswires

5 months ago

Guardant Health Agrees to $400 Million Open Market Sale of Shares

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
GH

Motley Fool

5 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening
GH

Business Wire

5 months ago

Guardant Health to Ring the Nasdaq Opening Bell on August 28 to Celebrate the Launch of Shield™ Blood Test for Colorectal Cancer Screening

GH

MT Newswires

5 months ago

UBS Raises Price Target on Guardant Health to $40 From $32, Maintains Buy Rating

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
GH

Motley Fool

5 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

GH

Morningstar Research

5 months ago

Analyst Report: Guardant Health, Inc.

Guardant Health Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GH

Simply Wall St.

5 months ago

Guardant Health Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Guardant Health to Participate in Upcoming Investor Conferences
GH

Business Wire

5 months ago

Guardant Health to Participate in Upcoming Investor Conferences

Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average
GH

Zacks

5 months ago

Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average

Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
GH

Zacks

5 months ago

Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates
GH

Zacks

5 months ago

Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates

GH

Associated Press Finance

5 months ago

Guardant Health: Q2 Earnings Snapshot

Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
GH

Business Wire

5 months ago

Guardant Health Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer
GH

Business Wire

5 months ago

Guardant Health COSMOS Study Published in Clinical Cancer Research Validates Utility of Guardant Reveal™ Liquid Biopsy Test for Predicting Recurrence in Colorectal Cancer

What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings
GH

Zacks

6 months ago

What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat
GH

Investor's Business Daily

6 months ago

Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat

Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer
GH

Business Wire

6 months ago

Guardant Health’s FDA-approved Shield™ Blood Test Now Commercially Available in U.S. as a Primary Screening Option for Colorectal Cancer

Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies
GH

Business Wire

6 months ago

Guardant Health Outcomes Model Confirms the Public Health Importance of Enhanced Colorectal Cancer Screening Outcomes with High Adherence Strategies

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
GH

Motley Fool

6 months ago

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Is It Too Late To Consider Buying Guardant Health, Inc. (NASDAQ:GH)?
GH

Simply Wall St.

6 months ago

Is It Too Late To Consider Buying Guardant Health, Inc. (NASDAQ:GH)?

Guardant Health secures FDA approval for Shield test
GH

Medical Device Network

6 months ago

Guardant Health secures FDA approval for Shield test

Guardant Health (GH) Moves 6.9% Higher: Will This Strength Last?
GH

Zacks

6 months ago

Guardant Health (GH) Moves 6.9% Higher: Will This Strength Last?

FDA approves Guardant Health's blood test for colon cancer
GH

Yahoo Finance Video

6 months ago

FDA approves Guardant Health's blood test for colon cancer

Guardant Health Gets FDA Nod on Colorectal Cancer Blood Test
GH

Investopedia

6 months ago

Guardant Health Gets FDA Nod on Colorectal Cancer Blood Test

GH

MT Newswires

6 months ago

Guardant Health's Shield Blood Test Approved by FDA; Shares Rise Pre-Bell

Guardant wins FDA approval for colon cancer blood test
GH

MedTech Dive

6 months ago

Guardant wins FDA approval for colon cancer blood test

GH

MT Newswires

6 months ago

Top Premarket Gainers

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening
GH

Business Wire

6 months ago

Guardant Health’s Shield™ Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024
GH

Business Wire

6 months ago

Guardant Health to Report Second Quarter 2024 Financial Results on August 7, 2024

Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance
GH

Business Wire

6 months ago

Guardant Health Introduces Major Smart Liquid Biopsy Upgrade to Market-Leading Guardant360® Test, Further Extending Its Best-in-Class Performance

Guardant settles allegations it violated the False Claims Act
GH

MedTech Dive

6 months ago

Guardant settles allegations it violated the False Claims Act

Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors
GH

Business Wire

6 months ago

Dr. Manuel Hidalgo Medina Joins Guardant Health Board of Directors

Baillie Gifford Reduces Stake in Guardant Health Inc.
GH

GuruFocus.com

7 months ago

Baillie Gifford Reduces Stake in Guardant Health Inc.

GH

MT Newswires

7 months ago

Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36

Guardant Health (GH) Just Overtook the 20-Day Moving Average
GH

Zacks

7 months ago

Guardant Health (GH) Just Overtook the 20-Day Moving Average

Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy?
GH

Zacks

7 months ago

Guardant Health (GH) Now Trades Above Golden Cross: Time to Buy?

Even after rising 7.4% this past week, Guardant Health (NASDAQ:GH) shareholders are still down 74% over the past three years
GH

Simply Wall St.

7 months ago

Even after rising 7.4% this past week, Guardant Health (NASDAQ:GH) shareholders are still down 74% over the past three years

GH

MT Newswires

8 months ago

Canaccord Genuity Adjusts Price Target on Guardant Health to $38 From $30, Maintains Buy Rating

Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer
GH

Business Wire

8 months ago

Guardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancer

Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials
GH

Business Wire

8 months ago

Guardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trials

Share on Social Networks: